FIELD: chemistry.
SUBSTANCE: invention relates to pharmaceutical chemistry, in particular to a process for preparing creatine amides of general formula shown below, which exhibit anti-ischemic activity. In formula R denotes amino acid residue of amino acid; Y denotes OR1, NR2R3, where R1 is H, CH2Ph, alkyl C1-C3, R2, R3 - H, alkyl C1-C4; X - low-molecular C1-C4 organic acid or mineral acid, or water. Method involves treating creatine para-toluenesulphonic acid in dimethyl formamide, followed by reacting obtained complex with derivatives of amino acids in presence of a condensing agent and a base. Condensing agent used is formic acid monoester chloride, wherein condensing agent and base are added simultaneously. Then an alkali metal acetate is added to obtained mixture, followed by distilling not less than 80 % of dimethyl formamide, extracting active ingredient with a aprotic polar solvent containing at least one ingredient from a group including acetone, tetrahydrofuran, methyl ethyl ketone and acetonitrile. Further, solvent was distilled off, residue is dissolved in a polar aprotic solvent containing at least one ingredient from a group consisting of water, ethanol and isopropyl alcohol, acetic and formic acid, p-toluenesulphonic acid is removed by anion-exchange chromatography on a sorbent. Solvent is removed in presence of low molecular weight C1-C4 organic acid or inorganic acid and alcohol at not more than pH 4.5, then treated with a solvent containing at least one ingredient from A group consisting of acetone, tetrahydrofuran, methyl ethyl ketone, ethyl acetate and acetonitrile. Active ingredient is extracted with a solvent containing at least one ingredient from a group consisting of ethyl and methyl alcohols are distilled off at least 70 % of solvent and treated with a solvent containing at least one ingredient from a group consisting of acetone, tetrahydrofuran, methyl ethyl ketone, acetonitrile, and acetate.
EFFECT: disclosed method increases output and purity of end product.
22 cl, 1 tbl, 25 ex
NH=C(NH2)-N(CH3)-CH2-CO-RY*X
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZIMIDAZOLE AND THEIR USING AS PRODRUGS OF PROTON PUMP INHIBITORS | 2003 |
|
RU2292342C2 |
KREATINE AMIDES, METHOD FOR ITS MAKING, NEUROPROTECTIVE AGENT | 2007 |
|
RU2354645C1 |
METHOD OF PRODUCING CREATINE AMIDES | 2009 |
|
RU2428414C2 |
DERIVATIVES OF 5-AMINOISOXAZOL - CONFORMATIONALLY-RIGID ANALOGS OF G-AMINO BUTYRIC ACID AND ITS PRODUCTION METHOD | 2016 |
|
RU2638530C2 |
METHOD OF PREPARATION 6α-METHYLHYDROCORTISONE OR ESTERS THEREOF FROM HYDROCORTISONE 21-ACETATE | 2017 |
|
RU2663484C1 |
METHOD FOR PRODUCING 6-METHYLENEHYDROCORTISONE OR ESTERS THEREOF FROM HYDROCORTISONE 21-ACETATE | 2017 |
|
RU2664101C1 |
PROCESS FOR THE PREPARATION OF 5-AMINOISOXAZOLE-CARBOXYLIC ACID | 2017 |
|
RU2658837C1 |
METHOD OF SYNTHESIS OF IMIDAZOLE DERIVATIVE | 1990 |
|
RU2026293C1 |
SUBSTANCE HAVING COMBINED ANTIAGGREGANT, ANTICOAGULANT AND VASODILATOR ACTIVITY, AND METHOD OF PRODUCING N, N '-SUBSTITUTED PIPERAZINES | 2014 |
|
RU2577039C2 |
PROTECTED DERIVATIVES OF VASOPRESSIN | 1997 |
|
RU2123498C1 |
Authors
Dates
2016-03-27—Published
2015-05-19—Filed